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Abstract
Background: In lacunar stroke patients vitamin B12 deficiency is often found and a relationship with the degree of
periventricular white matter lesions (pWMLs) is suggested. Given the known relationships between WMLs and depression
and between depression and fatigue after stroke, we studied both depression and fatigue in lacunar stroke patients with
and without vitamin B12 deficiency.
Methods: In 40 first-ever lacunar stroke patients vitamin B12 levels were determined and self-report questionnaires for
fatigue and depression were completed three months after stroke.
Results: Lacunar stroke patients with vitamin B12 deficiency (N=13) reported significantly more fatigue (90.7 versus 59.4;
p=.001) and depressive symptoms (6.62 versus 3.89; p,.05) than those without (N=27). In regression analyses, vitamin B12
deficiency was significantly and independently associated with the presence of severe fatigue and clinically significant
depression.
Conclusions: Our preliminary results suggest a relationship between vitamin B12 deficiency and increased levels of fatigue
and depression in lacunar stroke patients. If these findings could be replicated in a larger and general stroke sample, this
would open treatment options and may improve quality of life after stroke.
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Introduction
Recently, we found that around 30% of lacunar stroke patients
were vitamin B12 deficient [1] while in the normal elderly
population this is only 10–15% [2]. This deficiency was related to
the degree of periventricular white matter lesions (pWMLs) [1].
WMLs in turn are known to be related to depression [3], while
post-stroke depressive symptoms have been associated with an
increased risk of post-stroke fatigue [4]. Recently, the prevalence
of depression in lacunar stroke patients was found to be 35% [5].
The prevalence of fatigue in these patients is 38% [6]. So far, there
are no data available on the relationship between vitamin B12
deficiency and either depression or fatigue in lacunar stroke
patients. In the present study we aimed to compare levels of fatigue
and depression in first-ever lacunar stroke patients with and
without vitamin B12 deficiency.
Methods
1. Study population
We consecutively included 40 first-ever lacunar stroke patients
presenting at the Neurology Department of the Maastricht
University Medical Centre between February 2009 and October
2010. Lacunar stroke was defined as an acute stroke syndrome
with an ischemic lesion on brain MR compatible with the
occlusion of a single perforating small artery (subcortical,
demarcated, and a diameter ,20 mm). Patients with severe co-
morbidity, either neurological or psychiatric, were excluded.
Patients were assessed at 3 months after stroke to exclude acute
phase effects.
2. Ethics statement
The study was approved by the Medical Ethical Committee of
the Maastricht University Medical Centre and all patients signed
informed consent.
3. Assessments
Fatigue was measured by self-report with the Checklist
Individual Strength (CIS) [7]. The questionnaire contains 20
statements with total scores ranging from 20 to 140. The patient
has to indicate on a 7-point scale to what extent the statement is
applicable for him/her. A score .76 indicates severe fatigue [7].
Symptoms of depression were measured by self-report with the
Hospital Anxiety and Depression Scale-Depression subscale
(HADS-D) [8]. This subscale consists of 7 items with 4 possible
statements relating to the emotional aspects of depression. Total
scores range from 0 to 21. This subscale does not include physical
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use in somatic populations. Since suicidal items are lacking, the
instrument is less appropriate to assess the severity of depression.
However, a score .10 is considered clinically significant.
Stroke severity was measured with the National Institutes of
Health Stroke Scale (NIHSS) [9] on admission.
4. Vitamin B12 level
Vitamin B12 was measured in serum using a solid-phase time-
resolved fluoroimmunoassay. Vitamin B12 level ,150 pmol/L
was considered deficient [1], since this is clinically as well as
scientifically used as a cut-off to decide for vitamin B12 deficiency
[10]. Also, Pieters et al [1] used a cut-off of 2.5% at both ends,
which resulted in reference values between 150 and 630 pmol/L.
To further substantiate this lower reference value, they applied the
Bhattacharya-technique and found the lower limit also to be at
150 pmol/L.
5. Brain MRI
On brain MRI (standard T2-weighted and FLAIR sequences),
two experienced neurologists (JS and RvO) individually graded
pWMLs based on the Fazekas scale [11]. Extensive white matter
lesions were defined according to Fazekas classification as T-2
weighted irregular periventricular hyperintensities extending into
the deep white matter. In case of disagreement, lesions were
ascertained by consensus.
6. Statistical analysis
We used PASW Statistics 18 software. Differences between
groups were analyzed with Mann-Whitney U-tests and Pearson
Chi-square. We used logistic regression analyses to test associations
between the presence of severe fatigue and clinically significant
depression, and vitamin B12 status, adjusted for the presence of
extensive pWMLs. Since depression is found to be related to low
vitamin B12 levels in the elderly population [12], we also adjusted
for age.
Results
We included 40 lacunar stroke patients with a mean age of 67.9
years (SD=12.6), of which 15 (38%) females. Mean NIHSS score
was 3.42 (SD=2.30). All patients completed the questionnaires.
Vitamin B12 deficiency was present in 13 (33%) patients. The
mean CIS score was 69.6 (SD=27.6) and the mean HADS-D
score was 4.7 (SD=3.9). Severe fatigue was reported by 17
(42.5%) patients and clinically significant depressive symptoms by
6 (15%) patients.
Table 1 presents the results of the fatigue and depression
assessments in patients with and without vitamin B12 deficiency.
Patients with vitamin B12 deficiency had significantly higher
scores of overall fatigue and depressive symptoms.
Logistic regression analyses revealed that vitamin B12 deficien-
cy was significantly associated with the presence of severe fatigue
(p=.002), independent of age and the presence of extensive
pWMLs (table 2).
Discussion
The results showed vitamin B12 deficiency in 33% of our
sample of lacunar stroke patients. Those with deficiency reported
more fatigue and depressive symptoms than those without. In
addition, vitamin B12 deficiency was found to be associated with
fatigue and depressive symptoms independent of age and the
presence of pWMLs.
Depression and fatigue are known to be strongly correlated
[13]. Besides, fatigue is a common symptom of depression. To
increase the construct validity, we used the HADS-D scale for
Table 1. Demographics and mean scores for lacunar stroke patients with and without vitamin B12 deficiency.
With vitamin B12
deficiency (N=13)
Without vitamin B12 deficiency
(N=27) p
Age (SD) 66.6 (14.0) 68.6 (12.1) .795
Female (%) 7 (53.8) 8 (29.6) .138
NIHSS score (SD)* 3.0 (2.0) 3.6 (2.5) .506
CIS score (SD) 90.7 (20.0) 59.4 (25.0) .001
Severe fatigue (%) 11 (84.6) 6 (22.2) .000
HADS-D score (SD) 6.6 (4.0) 3.7 (3.5) .019
Clinically significant depressive symptoms 4 (30.8) 2 (7.4) .053
*NIHSS scores were only available for 9 (with vitamin B12 deficiency) and 15 (without deficiency) patients.
doi:10.1371/journal.pone.0030519.t001
Table 2. Logistic regression analyses on the presence of severe fatigue.
Model Independent variables b SE OR 95% CI for OR p-value
1 B12 deficiency 2.958 .897 19.250 3.316–111.747 .001
2 B12 deficiency 3.043 .971 20.976 3.130–140.549 .002
Age 2.039 .037 .961 .895–1.033 .280
Severe pWMLs 2.038 1.017 .963 .131–7.068 .970
Model 1: univariate analysis. Model 2: multivariate analysis with adjustments for age and the presence of severe pWMLs.
doi:10.1371/journal.pone.0030519.t002
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somatic items including fatigue, and as such we reduced the
overlap between the assessments of depression and fatigue.
Limitation of this study however is the cross-sectional design,
which makes it impossible to infer causality. To make causal
inferences from the relationships found, we need longitudinal
studies but preferably a randomized design.
Although we found a relationship between vitamin B12
deficiency and pWMLs in earlier work [1], WMLs did not affect
the relationship between vitamin B12 deficiency and either fatigue
or depressive symptoms. In this study we did not intend to
examine the direct relationships between pWMLs and both fatigue
and depression on the other hand. Larger samples are needed to
study all interrelationships. So far, the present results, though
preliminary, do not suggest a mediating role for WMLs in
explaining the relationship between vitamin B12 deficiency and
both fatigue and depression. Vitamin B12-induced anemia, on the
other hand, could be a mediating factor, since this may induce
fatigue. However, based on a retrospective search on hemoglobin-
values, there was only one patient with values below threshold.
Although not significant in our sample, prevalence rates of
vitamin B12 deficiency in general populations are higher for
women than for men [2]. It was suggested that this difference was
related to hormone replacement therapy, but this appeared not to
be a significant contributor to low vitamin B12 status [14].
Data about stroke severity (NIHSS) were not available for all
patients. Although we cannot exclude that stroke severity
influences the degree of fatigue and depression, we do not expect
a major effect as, in general, lacunar stroke patients present with
relatively mild neurological deficits.
Given the small sample size and cross-sectional design, our
findings are statistically only preliminary. However, since vitamin
B12 deficiency is easily treatable by suppletion, the results are
clinically relevant making further research worthwhile. Both
depression and fatigue may have a negative impact on
rehabilitation and quality of life after stroke [15]. If these findings
could be replicated in a larger and general stroke sample, this
would open treatment options and may improve quality of life
after stroke. Therefore, we suggest further research in these
populations as well as in elderly people with vitamin B12
deficiency. We also suggest adding functional assessments of
vitamin B12 deficiency such as homocysteine and methylmalonic
acid measurements. To infer causality, intervention studies with
vitamin B12 suppletion are warranted.
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